Sentences with phrase «treating other cancers»

That would make the nanoparticles good candidates for treating other cancers «located on the route,» he says.

As for treating other cancers, some, including most pancreatic and colon cancers, remain difficult to treat with a personalized vaccine because of their biochemical profile.

Although vinblastine has been used for decades to treat other cancers in dogs, it has only been in the last few years that it has been appreciated for its benefit in dogs with TCC.

Not exact matches

Founded in 2011, Innovent has built a portfolio of 16 potential products for treating cancer, autoimmune disorders and other diseases, and seven of those are in clinical development.

The drug may soon find a wider market if it can be shown effective in treating lymphoma and other blood cancers, and the price for those indications may well be different, based on their if value story.

He had been treated for cancer, pneumonia, and other ailments in recent years but died from natural causes.

The drugs have led to major advances in treating cancer and other diseases, but often come with a massive price tag.

Juno also has a few other compounds in early stages of development aimed at treating NHL, pediatric ALL, multiple myeloma, ovarian & breast cancer, AML, lung cancer, and more.

Celgene's lead product, Revlimid, a drug designed to treat multiple myeloma and a few other cancer types, has been benefiting from longer duration of use, strong pricing power, and high multiple myeloma market share.

Be sure to check out the thumbnails at the bottom of this post and visit the other bloggers who are posting amazing recipes today in support of Breast Cancer Awareness, and also for the 12 Weeks of Christmas Treats!

While study results indicated that combining capsaicin with the chemicals «might promote cancer cell survival,» the report clearly stated that the control group of mice treated only with capsaicin ``... did not induce any skin tumors...» In addition, the study repeatedly cited other research studies in which the anti-cancer properties of capsaicin were solidly demonstrated.

Because of its appeal to a variety of insects, conventional cotton gets treated with pesticides more than any other crop except coffee.The pesticides used, cyanide, dicofol, naled, propargite and trifluralin, are all known to cause cancer, and have been classified by the US Environmental Protection Agency as the most dangerous pesticides.

The state also announced it is in talks with Memorial Sloan - Kettering Cancer Center, which is treating hundreds of Health Republic customers, as well as other hospitals, to ensure access for up to one year, though it is not yet clear how that will be paid for.

Triple negative breast cancer is especially hard to treat because it lacks the receptors, such as the estrogen receptor, targeted with other cancer drugs.

And using cells from someone other than the cancer patient being treated might trigger an immune response against the foreign cells.

That number includes people treated for leukemia and other types of cancer, blood disorders and immune diseases.

The new name cites key features to guide pathologists in diagnosis, but omits the word «cancer,» indicating that it need not be treated with radioiodine or other aggressive approaches.

Although studies have shown EFVPTC is not dangerous, it is typically treated as aggressively as other types of thyroid cancer.

RADIATION therapy to treat cancer is more effective in some people than others.

With this technology, scientists could design and rapidly test new peptides to treat cancer and other diseases, as well as more effective variants of existing peptides, such as insulin, Pentelute says.

Glioblastoma is one of the most difficult cancers to treat — even after surgery and other therapies, it usually kills people within a year of diagnosis.

The researchers believe that similar models could eventually be used to treat other types of challenging cancers.

The findings, published in the Feb. 11 issue of the New England Journal of Medicine, could fundamentally change the way this cancer and others are treated.

They also report that inhibition of the FA pathway coupled with chemotherapy maybe be useful for treating other types of cancer.

However, along with this seemingly linear storyline in which retinoids block progesterone's promotion of CK5 + cells, previous work in the lab of CU Cancer Center investigator Peter Kabos, MD, and others shows that breast cancers treated with anti-estrogen drugs like tamoxifen or aromatase inhibitors show an increased population of CK5 + cells — it is as if these therapies remove the roadblock of estrogen - dependent cells, leaving CK5 + cells to proliferate.

The U.S. attorney's office in Indianapolis had alleged that Guoqing Cao and Shuyu Li, both naturalized U.S. citizens and senior biologists at Eli Lilly, passed research on tailored therapies for cancer and drugs to treat diabetes, obesity, and other metabolic disorders to Jiangsu Hengrui Medicine, a company in Lianyungang, China.

«Dr. Rassool and her colleagues have identified an exciting new mechanism for attacking cancer that may ultimately provide a new option for treating patients with leukemia and other cancers,» says E. Albert Reece, MD, PhD, MBA, vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and dean of UMSOM.

«This peptide is exciting in the sense that it provides a new alternative for treating these infections, which are predicted to kill more people annually than any other cause of death in our society, including cancer.»

Johns Hopkins Kimmel Cancer Center scientists first used cyclophosphamide to prevent severe graft - versus - host disease (GVHD) after bone marrow transplant involving haploidentical or «half - matched» transplants, a treatment first used in 2000 at the Cancer Center to treat leukemias and other blood cancers.

PARP inhibitors are used primarily to treat tumors linked to defects in BRCA genes, but may show promise in other cancers when combined with other drugs.

However, other research has suggested that the estrogen - like effects of isoflavones may reduce the effectiveness of endocrine therapies used to treat breast cancer.

Chemotherapy and radiotherapy alone are relatively unsuccessful in treating the disease, and while surgery to remove the tumour offers the best chance of survival, most patients are diagnosed when the cancer has already spread to other organs.

Because there was only one other published case report about a child with M. velutinosus — a 1 - year - old with brain cancer who had undergone a bone marrow transplant — Kumar notes that he and colleagues were at a loss as to how best to treat their patient.

Many groups around the world are investigating a wide range of other applications, including treating heart attacks, blindness, Parkinson's disease and cancer.

Some Hedgehog signaling reducing agents are currently on the market to treat specific types of cancers while others are in clinical trials.

«This approach offers a potentially new and safe way of treating liver cancer, and possibly other cancers,» said study senior author Dr. Ian Corbin, Assistant Professor in the Advanced Imaging Research Center (AIRC) and of Internal Medicine at UT Southwestern.

«Lots of ideas and efforts have been made to use NSAIDs to treat human pathologies, including colorectal cancer and other diseases,» Miller said.

Dr. Max Schwarz, an oncologist and clinical professor at Monash University in Melbourne, Australia, treated some brain - cancer patients with the experimental injectable form of Temodar and others with the capsule formulation.

«Pelvic RT after chemotherapy may be more beneficial in treating this form of ovarian cancer compared with other types,» Dr. Small said.

Identified via mammography and other screening technologies, DCIS is currently diagnosed annually in about 60,000 women in the U.S., and is generally treated similarly to other more advanced breast cancers with surgery and radiation therapy.

«Last week's vote represents 30 years» worth of work to find a new way to treat this devastating cancer and the start of a new era in using personalized immunotherapy to treat other types of cancers.»

However, this security system is so effective at protecting the brain that it prevents many life - saving drugs — all but some small molecules — from being able to treat cancer and other diseases of the brain.

The proposed CRISPR trial builds off the pioneering efforts of Carl June and others at University of Pennsylvania (UPenn) to genetically modify a cancer patient's own immune cells, specifically a class known as T cells, to treat leukemia and other cancers.

«Our findings are encouraging, as they suggest that entolimod can be safely combined with other chemotherapeutic, targeted or immunotherapeutic agents as treatment for advanced and very hard - to - treat cancers,» notes Dr. Adjei, who is Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park.

«This finding really excites us because it makes us think that this is a gene repair system that could be used to treat a range of diseases — not just tyrosinemia but others as well,» says Daniel Anderson, associate professor in MIT's Department of Chemical Engineering and a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES).

More recently, HCQ has shown promise in treating pancreatic cancer patients in ongoing clinical trials; however, its tolerability and effectiveness to stop autophagy in humans with other cancers has not been shown before.

Drugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other diseases, with two already on the market.

The finding, published in the current issue of the journal Nature Communications, could lead to new therapies for treating a common sub-type of GBM and possibly other forms of cancer.

But other types — colon and bladder cancer and certain leukemias, for example — are usually more aggressive and harder to treat.

The researchers plan to test additional potential targets in hopes that these particles could eventually be deployed to treat cancer, atherosclerosis, and other diseases.